Chiappetta Marco, Napolitano Antonio Giulio, Sassorossi Carolina, Nachira Dania, Lococo Filippo, Meacci Elisa, Scognamiglio Chiara, Congedo Maria Teresa, Santoro Gloria, D'Argento Ettore, Russo Jacopo, Horn Guido, Margaritora Stefano
Department of Thoracic Surgery, Fondazione Policlinico Universitario "A. Gemelli" IRCCS, Università Cattolica del Sacro Cuore, 00168 Rome, Italy.
Thoracic Surgery, Magna Graecia University, 88100 Catanzaro, Italy.
Cancers (Basel). 2025 Aug 26;17(17):2778. doi: 10.3390/cancers17172778.
Segmentectomy has recently been accepted as a valid anatomical resection in the early stages non-small cell lung cancer, even if different segment numbers and combinations are included. The aim of this study is to analyze prognostic factors in patients who underwent segmentectomy, with particular attention to segment numbers and characteristics. Characteristics of patients who underwent uniportal VATS segmentectomy from 1/01/2017 to 31/12/2022 were reviewed and retrospectively analyzed. Patients with nodal involvement and/or distant metastases, tumors > 4 cm, who received neoadjuvant treatment and those who underwent completion lobectomy were excluded. Operatory and pathological reports were reviewed to collect data on surgical characteristics and pathology. Segmentectomies were categorized according to numbers of resected segments as single/multiple. Clinico-pathological characteristics, number of segments and nodal parameters were associated to overall survival (OS) using Kaplan-Meier curves. The log-rank test was used to assess differences between subgroups. A multivariable model was built using Cox-regression analysis including variables with -values < 0.10 at univariable analysis. The final analysis was conducted on 95 patients who met the inclusion criteria. Multiple segmentectomies were performed in 47 (49.4%) cases, of which 37 (39%) were complex cases. At univariable analysis, tumor size ≤ 2 cm ( = 0.006, HR:0.260; 95%CI 0.099-0.686) significantly correlated with OS: patients with pT ≤ 2 cm presented a 5YOS of 85.3% vs. 48.3% of patients with pT >2 cm, with multivariable-confirmed tumor size ≤ 2 cm as an independent prognostic factor ( = 0.004, HR:0.204; 95%CI 0.069-0.607). Considering the tumor size according to number of resected segments, patients who underwent single segmentectomy presented a significantly better survival for pT ≤ 2 cm: 5YOS 91.7% vs. 41.3% for pT > 2 cm ( = 0.001). Conversely, no significant differences in OS were present in multiple segmentectomy: 5YOS 78.9% vs. 77.1% ( = 0.700). Similarly, pT ≤ 2 cm correlated with OS in complex segmentectomy ( = 0.010) but not in simple segmentectomy ( = 0.098). Our study confirms the distinct prognosis associated with tumor dimensions in patients who underwent uniportal VATS segmentectomy. We confirmed the tumor dimension cut-off of 2 cm as a robust prognosticator in single and complex segmentectomies. However, no significant differences in survival were observed in multiple and simple segmentectomies, implying that tumors larger than 2 cm may necessitate extended resections.
肺段切除术最近已被公认为是早期非小细胞肺癌有效的解剖性切除术,即使包括不同的肺段数量和组合。本研究的目的是分析接受肺段切除术患者的预后因素,尤其关注肺段数量和特征。回顾并回顾性分析了2017年1月1日至2022年12月31日接受单孔胸腔镜肺段切除术患者的特征。排除有淋巴结受累和/或远处转移、肿瘤>4 cm、接受新辅助治疗以及接受全肺叶切除术的患者。回顾手术和病理报告以收集手术特征和病理数据。根据切除的肺段数量将肺段切除术分为单肺段/多肺段。使用Kaplan-Meier曲线将临床病理特征、肺段数量和淋巴结参数与总生存期(OS)相关联。采用对数秩检验评估亚组间差异。使用Cox回归分析建立多变量模型,纳入单变量分析中P值<0.10的变量。最终对95例符合纳入标准的患者进行了分析。47例(49.4%)患者接受了多肺段切除术,其中37例(39%)为复杂病例。单变量分析显示,肿瘤大小≤2 cm(P = 0.006,HR:0.260;95%CI 0.099 - 0.686)与OS显著相关:pT≤2 cm的患者5年总生存率为85.3%,而pT>2 cm的患者为48.3%,多变量分析证实肿瘤大小≤2 cm是独立的预后因素(P = 0.004,HR:0.204;95%CI 0.069 - 0.607)。根据切除的肺段数量考虑肿瘤大小,接受单肺段切除术的患者pT≤2 cm时生存率显著更高:5年总生存率91.7%,而pT>2 cm时为41.3%(P = 0.001)。相反,多肺段切除术中OS无显著差异:5年总生存率78.9% vs. 77.1%(P = 0.700)。同样,在复杂肺段切除术中pT≤2 cm与OS相关(P = 0.010),而在简单肺段切除术中不相关(P = 0.098)。我们的研究证实了接受单孔胸腔镜肺段切除术患者的肿瘤大小与不同预后相关。我们确认2 cm的肿瘤大小临界值是单肺段和复杂肺段切除术中有力的预后指标。然而,在多肺段和简单肺段切除术中未观察到生存的显著差异,这意味着大于2 cm的肿瘤可能需要扩大切除范围。